279 related articles for article (PubMed ID: 19469063)
1. [Assessment of exercise testing on natriuretic peptide secretion in patients with atrial fibrillation].
Kurpesa M
Kardiol Pol; 2009 Mar; 67(3):262-4. PubMed ID: 19469063
[No Abstract] [Full Text] [Related]
2. Effects of exercise testing on natriuretic peptide secretion in patients with atrial fibrillation.
Wozakowska-Kapłon B; Opolski G
Kardiol Pol; 2009 Mar; 67(3):254-61. PubMed ID: 19378231
[TBL] [Abstract][Full Text] [Related]
3. Natriuretic peptide response to dynamic exercise in patients with atrial fibrillation.
Engelmann MD; Niemann L; Kanstrup IL; Skagen K; Godtfredsen J
Int J Cardiol; 2005 Oct; 105(1):31-9. PubMed ID: 16207542
[TBL] [Abstract][Full Text] [Related]
4. Exercise-induced natriuretic peptide secretion predicts cardioversion outcome in patients with persistent atrial fibrillation: discordant ANP and B-type natriuretic peptide response to exercise testing.
Wozakowska-Kaplon B; Opolski G
Pacing Clin Electrophysiol; 2010 Oct; 33(10):1203-9. PubMed ID: 20487352
[TBL] [Abstract][Full Text] [Related]
5. Predictive value of B-type natriuretic peptide for postoperative atrial fibrillation following pulmonary resection for lung cancer.
Nojiri T; Maeda H; Takeuchi Y; Funakoshi Y; Kimura T; Maekura R; Yamamoto K; Okumura M
Eur J Cardiothorac Surg; 2010 Apr; 37(4):787-91. PubMed ID: 19896864
[TBL] [Abstract][Full Text] [Related]
6. Natriuretic peptides in patients with atrial fibrillation.
Wozakowska-Kapłon B; Opolski G; Herman Z; Kosior D
Cardiol J; 2008; 15(6):525-9. PubMed ID: 19039756
[TBL] [Abstract][Full Text] [Related]
7. Oxygen uptake efficiency slope correlates with brain natriuretic peptide in patients with heart failure.
Straburzyńska-Migaj E; Gwizdała A; Siniawski A; Ochotny R; Grajek S
Cardiol J; 2010; 17(4):362-6. PubMed ID: 20690091
[TBL] [Abstract][Full Text] [Related]
8. Natriuretic peptides in patients with atrial fibrillation and advanced chronic heart failure: determinants and prognostic value of (NT-)ANP and (NT-pro) BNP.
Shelton RJ; Goode K; Cleland JG
Europace; 2007 Feb; 9(2):147; author reply 148. PubMed ID: 17227813
[No Abstract] [Full Text] [Related]
9. Plasma N-terminal fragments of natriuretic peptides predict the risk of stroke and atrial fibrillation in men.
Kurl S; Ala-Kopsala M; Ruskoaho H; Mäkikallio T; Nyyssönen K; Vuolteenaho O; Sivenius J; Salonen JT; Laukkanen JA
Heart; 2009 Jul; 95(13):1067-71. PubMed ID: 19321489
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of plasma B-type natriuretic peptide in predicting recurrence of atrial fibrillation one year after external cardioversion.
Lellouche N; Berthier R; Mekontso-Dessap A; Braconnier F; Monin JL; Duval AM; Dubois-Randé JL; Guéret P; Garot J
Am J Cardiol; 2005 Jun; 95(11):1380-2. PubMed ID: 15904651
[TBL] [Abstract][Full Text] [Related]
11. Changes in plasma natriuretic peptide levels in patients with atrial fibrillation after cardioversion.
Wozakowska-Kaplon B
Int J Cardiol; 2010 Oct; 144(3):436-7. PubMed ID: 19556018
[TBL] [Abstract][Full Text] [Related]
12. Cardiac response and N-terminal-pro-brain natriuretic peptide kinetics during exercise in patients with COPD.
Wang HY; Xu QF; Xiao Y; Zhang J; Sperry A
Respir Care; 2011 Jun; 56(6):796-9. PubMed ID: 21333081
[TBL] [Abstract][Full Text] [Related]
13. [Natriuretic peptides in atrial fibrillation. State of art and new concepts].
Wozakowska-Kapłon B; Opolski G
Kardiol Pol; 2004 Feb; 60(2):154-7. PubMed ID: 15116163
[No Abstract] [Full Text] [Related]
14. N-Terminal-proBrain natriuretic peptide measurement at presentation to identify patients with recent onset of atrial fibrillation.
Meune C; Wahbi K; Vermillet A; Guerin S; Aelion H; Weber S; Chenevier-Gobeaux C
Int J Cardiol; 2012 Jan; 154(2):208-9. PubMed ID: 22075419
[No Abstract] [Full Text] [Related]
15. Brain natriuretic peptide correlates with the extent of atrial fibrillation-associated silent brain lesions.
Gartner W; Zierhut B; Mineva I; Sodeck G; Leutmezer F; Domanovits H; Prayer D; Wolf F; Base W; Weissel M; Wagner L
Clin Biochem; 2008 Dec; 41(18):1434-9. PubMed ID: 18823968
[TBL] [Abstract][Full Text] [Related]
16. Ability of B-type natriuretic peptide in predicting postoperative atrial fibrillation in patients undergoing coronary artery bypass grafting.
Ata Y; Turk T; Ay D; Eris C; Demir M; Ari H; Ata F; Yavuz S; Ozyazicioglu A
Heart Surg Forum; 2009 Aug; 12(4):E211-6. PubMed ID: 19683991
[TBL] [Abstract][Full Text] [Related]
17. Congenital heart disease, exercise capacity and B-type natriuretic peptide.
Carvalho VO
Cardiol J; 2009; 16(5):489; author reply 490. PubMed ID: 19753535
[No Abstract] [Full Text] [Related]
18. Plasma mid-regional pro-atrial natriuretic peptide and N-terminal pro-brain natriuretic peptide improve discrimination of lone atrial fibrillation.
Chang IC; Chen LY; Chong JP; Austin E; Quay CN; Gong L; Mark Richards A; Ling LH
Int J Cardiol; 2015 Jun; 188():10-2. PubMed ID: 25880572
[No Abstract] [Full Text] [Related]
19. Questions regarding BNP assays.
Schwam E
Ann Emerg Med; 2006 Feb; 47(2):213-4; author reply 214. PubMed ID: 16431242
[No Abstract] [Full Text] [Related]
20. BNP/NT-proBNP and cardiac pacing: a review.
Wang RX; Guo T; Li XR
Pacing Clin Electrophysiol; 2009 Jun; 32(6):794-9. PubMed ID: 19545345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
